JD Mowery, new KBI Biopharma and Selexis SA CEO
April 20, 2023 11:38 AM EDTUpdated April 21, 09:16 AM
People
Pharma
Manufacturing

KBI Bio­phar­ma and Se­lex­is hire J.D. Mow­ery as new CEO

Tyler Patchen

News Reporter

KBI Bio­phar­ma is the lat­est con­tract man­u­fac­tur­er mak­ing change at the top in an on­go­ing C-suite shuf­fle oc­cur­ring across the CD­MO space over the past …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

A service from the Financial Times